Novanta Prices $300M Private Placement at 12.86% Discount, Diluting Shares by 6%

summarizeSummary

Novanta Inc. announced a $300 million private placement of common shares at a 12.86% discount to the current market price, leading to 6.01% dilution for existing shareholders, likely to fund a major acquisition.

check_boxKey Events

• Private Placement Priced

  Novanta Inc. entered into a Securities Purchase Agreement for a private placement of 2,142,857 common shares at $140.00 per share, raising approximately $300 million in gross proceeds.

• Significant Discount to Market Price

  The offering price of $140.00 per share is a 12.86% discount compared to the current market price of $160.65.

• Share Dilution

  The issuance of new shares will result in a 6.01% dilution for existing shareholders, based on 35,613,303 shares outstanding prior to the placement.

• Registration Rights Agreement

  The company also entered into a Registration Rights Agreement, committing to register the resale of the common shares sold in the private placement.

auto_awesomeAnalysis

Novanta Inc. has finalized a private placement to raise approximately $300 million by selling 2,142,857 common shares at $140.00 per share. This pricing represents a significant 12.86% discount compared to the current stock price of $160.65. The transaction will result in a 6.01% dilution for existing shareholders. This substantial capital raise, representing 5.24% of the company's market capitalization, is likely intended to fund the $1.45 billion acquisition of Riverpoint Medical, which was also announced today.